320 related articles for article (PubMed ID: 29727806)
41. A prevalence of posttransplantation cancers compared with cancers in people with human immunodeficiency virus/acquired immunodeficiency syndrome after highly active antiretroviral therapy.
Srisawat N; Avihingsanon A; Praditpornsilpa K; Jiamjarasrangsi W; Eiam-Ong S; Avihingsanon Y
Transplant Proc; 2008 Oct; 40(8):2677-9. PubMed ID: 18929833
[TBL] [Abstract][Full Text] [Related]
42. Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies.
Spagnuolo V; Galli L; Salpietro S; Gianotti N; Guffanti M; Cossarini F; Bigoloni A; Cinque P; Bossolasco S; Travi G; Fumagalli L; Lazzarin A; Castagna A
Int J Cancer; 2012 Jun; 130(12):2990-6. PubMed ID: 21796633
[TBL] [Abstract][Full Text] [Related]
43. Less cancer--or more--with HAART? Or, reflections on a late opus.
Mascolini M
J Int Assoc Physicians AIDS Care; 1998 Jun; 4(6):12-22. PubMed ID: 11365531
[TBL] [Abstract][Full Text] [Related]
44. The epidemiology of acquired immunodeficiency syndrome malignancies.
Goedert JJ
Semin Oncol; 2000 Aug; 27(4):390-401. PubMed ID: 10950365
[TBL] [Abstract][Full Text] [Related]
45. Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group.
Spano JP; Poizot-Martin I; Costagliola D; Boué F; Rosmorduc O; Lavolé A; Choquet S; Heudel PE; Leblond V; Gabarre J; Valantin MA; Solas C; Guihot A; Carcelain G; Autran B; Katlama C; Quéro L
Ann Oncol; 2016 Mar; 27(3):397-408. PubMed ID: 26681686
[TBL] [Abstract][Full Text] [Related]
46. Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030.
Shiels MS; Islam JY; Rosenberg PS; Hall HI; Jacobson E; Engels EA
Ann Intern Med; 2018 Jun; 168(12):866-873. PubMed ID: 29801099
[TBL] [Abstract][Full Text] [Related]
47. HIV-associated monoclonal gammopathy: a retrospective analysis of 25 patients.
Amara S; Dezube BJ; Cooley TP; Pantanowitz L; Aboulafia DM
Clin Infect Dis; 2006 Nov; 43(9):1198-205. PubMed ID: 17029142
[TBL] [Abstract][Full Text] [Related]
48. HIV-associated malignancies.
Safai B; Dias BM; Schwartz JJ; Boulier I
Antibiot Chemother (1971); 1991; 43():69-95. PubMed ID: 1883225
[No Abstract] [Full Text] [Related]
49. Malignant tumors and AIDS.
Nasti G; Vaccher E; Errante D; Tirelli U
Biomed Pharmacother; 1997; 51(6-7):243-51. PubMed ID: 9309244
[TBL] [Abstract][Full Text] [Related]
50. HIV-related Malignancies and Mimics: Imaging Findings and Management.
Javadi S; Menias CO; Karbasian N; Shaaban A; Shah K; Osman A; Jensen CT; Lubner MG; Gaballah AH; Elsayes KM
Radiographics; 2018; 38(7):2051-2068. PubMed ID: 30339518
[TBL] [Abstract][Full Text] [Related]
51. Changing incidence of AIDS-related Kaposi sarcoma and non-Hodgkin lymphoma in Ontario, Canada.
Bahl S; Theis B; Nishri D; Marrett LD
Cancer Causes Control; 2008 Dec; 19(10):1251-8. PubMed ID: 18618279
[TBL] [Abstract][Full Text] [Related]
52. Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study.
Hernández-Ramírez RU; Qin L; Lin H; Leyden W; Neugebauer RS; Althoff KN; Achenbach CJ; Hessol NA; D'Souza G; Gebo KA; Gill MJ; Grover S; Horberg MA; Li J; Mathews WC; Mayor AM; Park LS; Rabkin CS; Salters K; Justice AC; Moore RD; Engels EA; Silverberg MJ; Dubrow R;
Lancet HIV; 2019 Apr; 6(4):e240-e249. PubMed ID: 30826282
[TBL] [Abstract][Full Text] [Related]
53. Ten years later: a single hospital experience with malignancy in HIV/AIDS.
Reed M; Cosgrove JM; Cindrich R; Parithivel VS; Gad Y; Bangalore M; Uzor R; Kalim J; Segura R; Albu E
J Surg Oncol; 2010 Sep; 102(3):282-6. PubMed ID: 20740588
[TBL] [Abstract][Full Text] [Related]
54. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.
Monforte Ad; Abrams D; Pradier C; Weber R; Reiss P; Bonnet F; Kirk O; Law M; De Wit S; Friis-Møller N; Phillips AN; Sabin CA; Lundgren JD;
AIDS; 2008 Oct; 22(16):2143-53. PubMed ID: 18832878
[TBL] [Abstract][Full Text] [Related]
55. Incidence of malignancy in a Spanish cohort of patients infected by the human immunodeficiency virus.
Cañas-Ruano E; Martín-Castillo M; Raventós B; Burgos J; Curran A; Navarro J; García J; Suanzes P; Ribera E; Falcó V
Med Clin (Barc); 2020 Oct; 155(7):288-294. PubMed ID: 32005558
[TBL] [Abstract][Full Text] [Related]
56. AIDS and non AIDS-related malignant lymphoma in Tanzania.
Kaaya EE; Castaños-Velez E; Ekman M; Mwakigonja A; Carneiro P; Lema L; Kitinya J; Linde A; Biberfeld P
Afr Health Sci; 2006 Jun; 6(2):69-75. PubMed ID: 16916294
[TBL] [Abstract][Full Text] [Related]
57. Breast cancer in women living with HIV.
D'Andrea F; Ceccarelli M; Facciolà A; Nunnari G; Pellicanò GF; Venanzi Rullo E
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1158-1164. PubMed ID: 30779085
[TBL] [Abstract][Full Text] [Related]
58. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
[TBL] [Abstract][Full Text] [Related]
59. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
[TBL] [Abstract][Full Text] [Related]
60. Re: "Temporal trends in the incidence of non-Hodgkin's lymphoma and selected malignancies in a population with a high incidence of acquired immunodeficiency syndrome (AIDS)".
Horn PL; DeLorenze GN; Brown SR; Holly EA; West DW
Am J Epidemiol; 1989 Nov; 130(5):1069-71. PubMed ID: 2816897
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
